You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Medtronic
Colorcon
Moodys
Baxter

Last Updated: April 4, 2020

DrugPatentWatch Database Preview

Aurobindo Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for AUROBINDO, and what generic and branded alternatives to AUROBINDO drugs are available?

AUROBINDO has three hundred and seventy-six approved drugs.

There are nineteen tentative approvals on AUROBINDO drugs.

Summary for Aurobindo
US Patents:0
Tradenames:280
Ingredients:255
NDAs:376
Patent Litigation for Aurobindo: See patent lawsuits for Aurobindo

Drugs and US Patents for Aurobindo

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd LAMIVUDINE lamivudine TABLET;ORAL 077464-002 Nov 21, 2016 AB RX No No   Start Trial   Start Trial
Aurobindo METFORMIN HYDROCHLORIDE metformin hydrochloride TABLET;ORAL 077095-003 Jan 14, 2005 AB RX No No   Start Trial   Start Trial
Aurobindo Pharma Ltd ATOMOXETINE HYDROCHLORIDE atomoxetine hydrochloride CAPSULE;ORAL 079016-001 May 30, 2017 AB RX No No   Start Trial   Start Trial
Aurobindo Pharma DIDANOSINE didanosine CAPSULE, DELAYED REL PELLETS;ORAL 090094-004 Sep 24, 2008 AB RX No No   Start Trial   Start Trial
Aurobindo Pharma Ltd METFORMIN HYDROCHLORIDE metformin hydrochloride TABLET, EXTENDED RELEASE;ORAL 079118-002 Jul 20, 2012 AB RX No No   Start Trial   Start Trial
Aurobindo Pharma Ltd OLMESARTAN MEDOXOMIL olmesartan medoxomil TABLET;ORAL 204798-002 Apr 24, 2017 AB RX No No   Start Trial   Start Trial
Aurobindo Pharma AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 065499-005 Aug 17, 2010 AP RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for AUROBINDO drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Moodys
Baxter
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.